Long Follow-up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma (RATHL) Trial (CRUK/07/033) Confirms the Safety of Both De-Escalation and Intensification of Chemotherapy
暂无分享,去创建一个
F. d'Amore | J. Radford | M. Federico | S. Barrington | A. Fosså | G. Enblad | D. Molin | J. Trotman | S. Luminari | L. Berkahn | A. Kirkwood | Peter W M Johnson